3D189

3D Medicines · Phase 1 active Biologic

At a glance

Generic name	3D189
Sponsor	3D Medicines
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of 3D189 in Patients With Hematologic Malignancies (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

3D189 CI brief — competitive landscape report
3D189 updates RSS · CI watch RSS
3D Medicines portfolio CI